Zume
Search results
Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.
Oct 19, 2022 · Ginkgo Bioworks, a company that designs and builds biological systems, announces its completed acquisition of Zymergen, a company that develops automation and software solutions for biological engineering. The acquisition is expected to enhance Ginkgo's platform and expand its product concepts and partnerships.
Jul 25, 2022 · Zymergen, a synthetic biology company that shifted to drug discovery in January, has been acquired by Ginkgo Bioworks for $300 million. Ginkgo plans to integrate Zymergen's automation and software into its cell engineering platform, while evaluating strategic alternatives for its drug discovery business.
Oct 19, 2022 · Ginkgo Bioworks, a biotech company that programs cells, has completed its acquisition of Zymergen, a biotech company that designs and produces molecules, microbes and materials. The acquisition is expected to enhance Ginkgo's platform and expand its applications across diverse markets.
Oct 13, 2021 · Zymergen’s stock tanked 69% that day, wiping out nearly $2.5 billion in market value. The disclosure was shocking for a company that had raised more than $1 billion in venture funding and $530...
Aug 4, 2021 · On Tuesday afternoon, synthetic biology manufacturing company Zymergen said its cofounder and CEO would be stepping down immediately and that the company, which just went public in April, would...
Jun 3, 2024 · Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
